Citigroup Global Markets India informs about Post Open Offer Status

24 Jul 2015 Evaluate

Citigroup Global Markets India (‘Manager to the Offer’), on behalf of Sun Pharmaceutical Industries Limited (‘Sun Pharma’/ ‘Acquirer’), has informed this Post Offer Announcement to the Shareholders of Zenotech Laboratories Limited (‘Zenotech’ / ‘Target Company’), pursuant to Regulation 18(12) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (‘SEBI (SAST) Regulations’) in respect of the open offer (‘Offer’) for acquisition of up to 9,693,332  fully paid up equity shares (Shares) representing 28.16% of the fully diluted share capital of the Target Company, pursuant to and in compliance with Regulations 3(1), 4 and 5(1) of the SEBI (SAST) Regulations.This Announcement should be read in continuation and in conjunction with the Public Announcement dated April 11, 2014 (PA), the Detailed Public Statement with respect to the aforementioned Offer dated March 30, 2015 (DPS), the Letter of Offer dated June 18, 2015 (Letter of Offer), and the Offer Opening Advertisement published on June 29, 2015.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1639.30 7.65 (0.47%)
27-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.30
Dr. Reddys Lab 1240.00
Cipla 1312.85
Zydus Lifesciences 893.45
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×